Last quarter (Q3 2024), Appili Therapeutics Inc Class A's total revenue was C$478.40K, an increase of Infinity% from the same quarter last year. In Q3, Appili Therapeutics Inc Class A's net income was C$-152.34K. See Appili Therapeutics Inc Class A’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	C$ 1.15M	C$ 334.18K	C$ 1.39M	-	C$ 199.11K	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	C$ 1.15M	C$ 334.18K	C$ 1.39M	-	-	-
Operating Expense	C$ 9.02M	C$ 8.25M	C$ 26.07M	C$ 14.37M	C$ 5.64M	C$ 4.37M
Operating Income	C$ -7.87M	C$ -7.91M	C$ -24.68M	C$ -14.37M	C$ -5.44M	C$ -4.37M
Net Non Operating Interest Income Expense	C$ -1.70M	C$ -1.10M	C$ -1.55M	C$ -47.12K	C$ 28.06K	C$ 41.48K
Other Income Expense	C$ -4.11M	C$ -138.47K	C$ 1.06M	-	-	-
Pretax Income	C$ -5.23M	C$ -9.21M	C$ -27.32M	C$ -14.33M	C$ -5.42M	C$ -4.33M
Tax Provision	C$ 67.50K	C$ 36.39K	C$ 38.46K	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -5.30M	-	C$ -27.36M	C$ -14.33M	C$ -5.42M	C$ -4.33M
Basic EPS	C$ -0.04	-	C$ -0.38	C$ -0.24	C$ -0.16	C$ -0.13
Diluted EPS	C$ -0.04	-	C$ -0.38	C$ -0.24	C$ -0.16	C$ -0.13
Basic Average Shares	C$ 485.15M	-	C$ 66.73M	C$ 59.18M	C$ 34.33M	C$ 33.59M
Diluted Average Shares	C$ 485.15M	-	C$ 66.73M	C$ 59.18M	C$ 34.33M	C$ 33.59M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 4.80M	-	-	C$ -14.37M	C$ 5.64M	C$ 4.37M
Net Income From Continuing And Discontinued Operation	C$ -5.30M	-	C$ -27.36M	C$ -14.33M	C$ -5.42M	C$ -4.33M
Normalized Income	C$ -3.84M	C$ -6.77M	C$ -20.08M	C$ -10.53M	C$ -5.42M	C$ -4.33M
Interest Expense	-	-	-	-	C$ 12.11K	C$ -41.48K
EBIT	C$ -3.53M	C$ -8.11M	C$ -25.76M	C$ -14.26M	C$ -5.40M	C$ -4.29M
EBITDA	C$ -3.52M	C$ -8.10M	C$ -25.75M	C$ -14.24M	C$ -5.39M	C$ -4.27M

Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing